Related Experiment Videos
Long-term outcome after mesenteric artery reconstruction: a 37-year experience
Jae-Sung Cho1, John A Carr, Gordon Jacobsen
1Division of Vascular Surgery, Department of Surgery, Henry Ford Hospital, Detroit, MI 48202, USA. jcho1@hfhs.org
Journal of Vascular Surgery
|March 6, 2002
Summary
Mesenteric artery reconstruction (MAR) for atherosclerotic mesenteric ischemia shows long-term patency and symptom-free survival, particularly for chronic cases. Acute mesenteric ischemia (AMI) remains lethal, but successful MAR offers comparable outcomes to chronic cases.
Area of Science:
- Vascular Surgery
- Gastroenterology
- Cardiovascular Medicine
Background:
- Atherosclerotic mesenteric ischemia affects the arteries supplying blood to the intestines.
- Mesenteric artery reconstruction (MAR) is a surgical intervention to restore blood flow.
- Differentiating outcomes between acute (AMI) and chronic (CMI) mesenteric ischemia is crucial.
Purpose of the Study:
- To define the long-term results of mesenteric artery reconstruction (MAR).
- To identify factors influencing outcomes after MAR for atherosclerotic mesenteric ischemia.
- To compare outcomes between acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI).
Main Methods:
- Retrospective review of 48 patients (66 arteries) undergoing MAR for AMI or CMI.
- Procedures included bypass grafting, local endarterectomy (LEA), and transaortic endarterectomy (TAE).
- Follow-up averaged 5.3 years, assessing patency, recurrence, and survival rates.
Main Results:
- Perioperative mortality was 52% for AMI versus 0% for CMI.
- Cumulative patency rates were 57% at 5 years and 46% at 10 years.
- Transaortic endarterectomy (TAE) showed improved patency over LEA; symptomatic recurrences were linked to superior mesenteric artery (SMA) thrombosis.
Conclusions:
- Acute mesenteric ischemia (AMI) is a high-mortality condition, while MAR for chronic mesenteric ischemia (CMI) has low mortality.
- Successful MAR for AMI can achieve long-term patency and symptom-free survival comparable to CMI.
- Elective MAR for CMI is recommended, with long-term surveillance advised.